Apolipoprotein B is associated with metabolic syndrome in Chinese families with familial combined hyperlipidemia, familial hypertriglyceridemia and familial hypercholesterolemia

International Journal of Cardiology

Volumn 116, Issue 2, 2007, Pages 194-200

  Pei, Wei dong ^a   Sun, Yu hua ^a   Lu, Bin ^b   Liu, Qun ^b   Zhang, Chao yang ^a   Zhang, Jian ^a   Jia, Yu he ^a   Lu, Zong liang ^a   Hui, Ru tai ^a,b   Liu, Li sheng ^a   Yang, Yue jin ^a  

^a Cardiovascular Institute   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

Apolipoprotein B; Familial combined hyperlipidemia; Familial hypercholesterolemia; Familial hypertriglyceridemia; Metabolic syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANALYTIC METHOD; ARTICLE; BODY MASS; CHINESE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNICITY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK; WAIST CIRCUMFERENCE;

ADULT; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PREVALENCE;

EID: 33846986327     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.03.045     Document Type: Article

References (41)

1. Reaven G. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
2. Tan C.E., Chew S.K., Ma S., Tai E.S., and Wai D. Can we apply the National Cholesterol Education Program Adult Treatment Panel Definition of the metabolic syndrome to Asians. Diabetes Care 27 (2004) 1182-1186
3. Reilly M.P., and Rader D.J. The metabolic syndrome. More than the sum of its parts?. Circulation 108 (2003) 1546-1551
4. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
5. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2509
6. Haffner S., and Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 108 (2003) 1541-1545
7. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications, I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15 (1998) 539-553
8. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults. Findings from the third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
9. Cheng T.O. Metabolic syndrome in China. Circulation 109 14 (2004) e180
10. Kereiakes D., and Willerson J.T. Metabolic syndrome epidemic. Circulation 108 (2003) 1552-1553
11. Jia W.P., Xiang K.S., Chen L., Lu J.X., and Wu Y.M. Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 3 (2002) 157-165
12. Brunzell J.D., and Hokanson J.E. Dyslipidemia of central obesity and insulin resistance. Diabetes Care 22 suppl 3 (1999) C10-C13
13. Goldstein J.L., Schrott H.G., Hazzard W.R., Bierman E.L., and Motulsky A.G. Hyperlipidemia in coronary heart disease, II: genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
14. Austin M.A., McKnight B., Edwards K.L., et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 101 (2000) 2777-2782
15. Hopkins P.N., Heiss G., Ellison C., et al. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia. A case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation 108 (2003) 519-523
16. Hunt S.C., Wu L.L., Hopkins P.N., et al. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis 9 (1989) 335-344
17. Sniderman A.D. How, when, and why to use apolipoprotein B in clinical practice. Am J Cardiol 90 (2002) 48i-54i [suppl]
18. Kwiterovich Jr. P.O. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol 90 (2002) 30i-47i [suppl]
19. Sattar N., Williams K., Sniderman A.D., D'Agostino R., and Haffner S.M. Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis Study. Circulation 110 (2004) 2687-2693
20. Schuster H., Lamprecht A., Junghans C., et al. Approaches to the genetics of cardiovascular disease through genetic field work. Kidney Int 53 (1998) 1449-1454
21. Friedewald W.T., Levy R.I., and Fredrickson D.S. Friedewald formula: estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of preparative ultracentrifugation. Clin Chem 18 (1972) 499-502
22. Wang Z.L. Epidemiology of cholesterol and coronary heart disease. Clinical blood lipodology (1997), Hunan Science and Technology Press, Changsha
23. Zhou B.F., Wu Y.F., Yang J., Li Y., Zhang H.Y., and Zhao L.C. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev 3 (2002) 147-156
24. Zhou B.F. Predictive value of body mass index and waist circumference for risk factors of certain related disease in Chinese adults - study on optimal cut-off point of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15 (2002) 83-95
25. Li G., Chen X., Jang Y., et al. Obesity, coronary heart disease risk factors and diabetes in Chinese: an approach to the criteria of obesity in the Chinese population. Obes Rev 3 (2002) 167-172
26. Fagan T.C., and Deedwania P.C. The cardiovascular dysmetabolic syndrome. Am J Med 105 1A (1998) 77S-82S
27. Anand S.S., Yi Q.L., Gerstein H., et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease. Circulation 108 (2003) 420-425
28. O'Brien T., Nguyen T.T., Hallaway B.J., et al. The role of lipoprotein A-1 and lipoprotein A-1/A-2 in predicting coronary artery disease. Arterioscler Thromb Vasc Biol 15 (1995) 228-231
29. Wald N.J., Law M., Watt H.C., et al. Apolipoproteins and ischemic heart disease: implication for screening. Lancet 343 (1994) 75-79
30. Keulen E.T., Kruijshoop M., Schaper N.C., Hoeks A.P., and de Bruin T.W. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B. Arterioscler Thromb Vasc Biol 22 (2002) 283-288
31. Pei W.D., Baron H., Muller-Myhsok B., et al. Support for linkage of familial combined hyperlipidemia to chromosome 1q21-23 in Chinese and German families. Clin Genet 57 (2000) 29-34
32. Wilson P.W.F., and Grundy S.M. The metabolic syndrome. A practical guide to origin and treatment: part I. Circulation 108 (2003) 1537-1540
33. Chen C.H., Lin K.C., Tsai S.T., and Chou P. Different association of hypertension and insulin-related metabolic syndrome between men and women in 8437 nondiabetic Chinese. Am J Hypertens 13 (2000) 846-853
34. Lee Y.J., and Tsai J.C.R. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 25 (2002) 1002-1008
35. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and feature of the metabolic syndrome: a population based study. Diabetes Care 23 (2000) 1835-1839
36. Wild S., Sicree R., Roglic G., King H., and Green A. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
37. WHO expert consultation: appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
38. Han T.S., Williams K., Sattar N., Hunt K.J., Lean M.E., and Haffner S.M. Prospective analysis of obesity, body fat distribution and hyperinsulinaemia in the development of metabolic syndrome in the San Antonio Heart Study. Obes Res 10 (2002) 923-931
39. Stevens J., Couper D., Pankow J., et al. Sensitivity and specificity of anthropometrics for the prediction of diabetes in a biracial cohort. Obes Res 9 (2001) 696-705
40. Wang J., Thornton J.C., Russell M., Burastero S., Heymsfield S.B., and Pierson R.N. Asians have lower BMI but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 60 (1994) 23-28
41. Cooperative Meta-Analysis group of China Obesity Task Force. Predictive value of body mass index and waist circumference to risk factors of related diseases in Chinese adult populations [Chinese]. Chin J Epidemiol 23 (2002) 5-10